Aprea Therapeutics, Inc. (APRE) › Net IncomeAprea Therapeutics, Inc. (APRE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$15.19M2018: -$15.53M2019: -$28.06M2020: -$53.48M2021: -$37.13M2022: -$112.66M2023: -$14.29M2024: -$12.96M2025: -$12.60M-$12.60M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$12.60M+2.8%2024-$12.96M+9.3%2023-$14.29M+87.3%2022-$112.66M-203.4%2021-$37.13M+30.6%2020-$53.48M-90.6%2019-$28.06M-80.7%2018-$15.53M-2.2%2017-$15.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share